Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -19.50p -1.21% 1,595.50p 1,589.50p 1,590.00p 1,616.00p 1,585.50p 1,615.00p 12,990,619 16:35:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,889.0 1,939.0 18.8 84.9 78,345.34

GlaxoSmithKline PLC Director/PDMR Shareholding

16/03/2017 4:13pm

UK Regulatory (RNS & others)


GlaxoSmithKline (LSE:GSK)
Historical Stock Chart

6 Months : From Jan 2017 to Jul 2017

Click Here for more GlaxoSmithKline Charts.

TIDMGSK

RNS Number : 7375Z

GlaxoSmithKline PLC

16 March 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ======================================================================= 
 a)   Name                     Dr M M Slaoui 
===  ========================  ============================================= 
 b)   Position/status          Chairman, Global Vaccines 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  ============================================= 
 b)   Nature of the             An increase of 4 ADSs following the notional 
       transaction               allocation of ADSs on 15 March 2017, at 
                                 a price of $42.00 per ADS, as a result 
                                 of the revaluation of the cash element 
                                 of the notional investment held within 
                                 the GSK 401(K) plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $42.00     4 
                                 ---------  ---------- 
===  ========================  ============================================= 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2017-03-15 
===  ========================  ============================================= 
 f)   Place of the              n/a 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ======================================================================= 
 a)   Name                     Dr K Slaoui 
===  ========================  ============================================= 
 b)   Position/status          PCA of Dr M M Slaoui (Chairman, Global 
                                Vaccines) 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            GlaxoSmithKline plc American Depositary 
       the financial             Shares ('ADSs') 
       instrument                ISIN: US37733W1053 
===  ========================  ============================================= 
 b)   Nature of the            An increase of 91 ADSs following the notional 
       transaction              allocation of ADSs on 15 March 2017, at 
                                a price of $42.00 per ADS, as a result 
                                of the revaluation of the cash element 
                                of the notional investment held within 
                                the GSK 401(K) plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $42.00     91 
                                 ---------  ---------- 
===  ========================  ============================================= 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2017-03-15 
===  ========================  ============================================= 
 f)   Place of the              n/a 
       transaction 
===  ========================  ============================================= 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQQLFFDXFFBBF

(END) Dow Jones Newswires

March 16, 2017 12:13 ET (16:13 GMT)

1 Year GlaxoSmithKline Chart

1 Year GlaxoSmithKline Chart

1 Month GlaxoSmithKline Chart

1 Month GlaxoSmithKline Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V:gb D:20170725 04:26:56